Effect of BDNF Val66Met and serotonin transporter 5-HTTLPR polymorphisms on psychopathological characteristics in a sample of university students

Psychiatric Genetics

Volumn 23, Issue 5, 2013, Pages 188-197

  Kourmouli, Niki ^a   Samakouri, Maria ^a   Mamatsiou, Athina ^a   Trypsianis, Gregory ^a   Livaditis, Miltos ^a   Veletza, Stavroula ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; SEROTONIN TRANSPORTER; SEROTONIN TRANSPORTER LINKED POLYMORPHIC REGION; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DEPRESSION; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROSIS; OBSESSIVE COMPULSIVE DISORDER; PARANOIA; PHOBIA; PRIORITY JOURNAL; PSYCHOPATHY; PSYCHOSIS; SOCIAL STATUS; SOMATIZATION;

ADOLESCENT; ADULT; ANTISOCIAL PERSONALITY DISORDER; ANXIETY; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STUDENTS; UNIVERSITIES; YOUNG ADULT;

EID: 84883653018     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0b013e3283643629     Document Type: Article

References (91)

1. Aguilera M, Arias B, Wichers M., Barrantes-Vidal N, Moya J, Villa H., et al. (2009). Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population. Psychol Med 39:1425-1432.
2. Alexander N, Osinsky R, Schmitz A., Mueller E, Kuepper Y, Hennig J. (2010). The BDNF Val66Met polymorphism affects HPA-axis reactivity to acute stress. Psychoneuroendocrinology 35:949-953.
3. Anguelova M, Benkelfat C, Turecki G. (2003). A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Mol Psychiatry 8:646-653. (Pubitemid 36976297)
4. Arias B, Aguilera M, Moya J., Saiz PA, Villa H, Ibanez MI, et al (2012). The role of genetic variability in the SLC6A4, BDNF and GABRA6 genes in anxiety-related traits. Acta Psychiatr Scand 125:194-202.
5. Baca-Garcia E., Salgado BR, Segal H.D., Lorenzo CV, Acosta MN, Romero MA, et al (2005). A pilot genetic study of the continuum between compulsivity and impulsivity in females: the serotonin transporter promoter polymorphism. Prog Neuropsychopharmacol Biol Psychiatry 29:713-717. (Pubitemid 40897781)
6. Bhang S, Ahn JH, Choi S.W. (2011). Brain-derived neurotrophic factor and serotonin transporter gene-linked promoter region genes alter serum levels of brain-derived neurotrophic factor in humans. J Affect Disord 128:299-304.
7. Brown JS (2003). The serotonin transporter gene's association with mental disorders: a metaanalysis. Florida: Department of Psychology, The Florida State University College of Arts and Sciences.
8. Bueller JA, Aftab M, Sen S., Gomez-Hassan D, Burmeister M, Zubieta J.K. (2006). BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 59:812-815.
9. Calabrese F, Molteni R, Racagni G., Riva M.A. (2009). Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 34 (Suppl 1): S208-S216.
10. Calati R, De Ronchi D, Bellini M, Serretti A. (2011). The 5-HTTLPR polymorphism and eating disorders: a meta-analysis. Int J Eat Disord 44:191-199.
11. Caspi A, Sugden K, Moffitt T.E., Taylor A., Craig IW, Harrington H, et al (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389. (Pubitemid 36877077)
12. Castren E (2005). Is mood chemistry? Nat Rev Neurosci 6:241-246. (Pubitemid 40342418)
13. Chen L, Lawlor DA, Lewis S.J., Yuan W., Abdollahi MR, Timpson NJ, et al (2008). Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 147B:814-821.
14. Chen ZY, Patel PD, Sant G, Meng C.X., Teng KK, Hempstead BL, Lee F.S. (2004). Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 24:4401-4411. (Pubitemid 38608151)
15. Chepenik LG, Fredericks C, Papademetris X., Spencer L, Lacadie C, Wang F., et al. (2009). Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology 34:944-951.
16. Chorbov VM, Lobos EA, Todorov A.A., Heath AC, Botteron KN, Todd R.D. (2007). Relationship of 5-HTTLPR genotypes and depression risk in the presence of trauma in a female twin sample. Am J Med Genet B Neuropsychiatr Genet 144B:830-833. (Pubitemid 47417217)
17. Clarke H, Flint J, Attwood A.S., Munafo M.R. (2010). Association of the 5-HTTLPR genotype and unipolar depression: a meta-analysis. Psychol Med 40: 1767-1778.
18. Daftary SS, Calderon G, Rios M. (2012). Essential role of brain-derived neurotrophic factor in the regulation of serotonin transmission in the basolateral amygdala. Neuroscience 224:125-134.
19. Derogatis LR (1994). Symptoms Checklist-90-R (SCL-90-R): Administration, Scoring Procedures manual. 3rd ed. Minneapolis: National Computer Systems Inc. pp. 5-7.
20. Dimitriou E (1986). The Eysenck Personality Questionnaire (EPQ). The validity of the Greek, adult and junior version. Engefalos 12:41-54.
21. Donias S, Karastergiou A, Manos N. (1991). Standardization of the symptom checklist-90-R rating scale in a Greek population. Psychiatriki 2:42-48.
22. Duncan LE, Hutchison KE, Carey G, Craighead W.E. (2009). Variation in brain-derived neurotrophic factor (BDNF) gene is associated with symptoms of depression. J Affect Disord 115 (1-2):215-219.
23. Egan MF, Kojima M, Callicott J.H., Goldberg TE, Kolachana BS, Bertolino A, et al (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257-269. (Pubitemid 36144114)
24. Eysenck HJ, Eysenck S. (1975). Manual of the EPQ (Personality Questionnaire). London: Hodder and Stoughton Educational. pp. 41-54.
25. Fountoulakis K, Iacovides A, Kleanthous S., Samolis S, Kaprinis SG, Sitzoglou K, et al (2001). Reliability, validity and psychometric properties of the Greek translation of the Center for Epidemiological Studies-Depression (CES-D) Scale. BMC Psychiatry 1:3.
26. Frodl T, Schule C, Schmitt G., Born C, Baghai T, Zill P., et al. (2007). Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry 64: 410-416. (Pubitemid 46556460)
27. Frodl T, Zill P, Baghai T., Schule C, Rupprecht R, Zetzsche T., et al. (2008). Reduced hippocampal volumes associated with the long variant of the tri-and diallelic serotonin transporter polymorphism in major depression. Am J Med Genet B Neuropsychiatr Genet 147B:1003-1007.
28. Frustaci A, Pozzi G, Gianfagna F., Manzoli L, Boccia S. (2008). Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. Neuropsychobiology 58 (3-4):163-170.
29. Geller B, Badner JA, Tillman R, Christian S.L., Bolhofner K., Cook EH Jr (2004). Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 161:1698-1700. (Pubitemid 39201469)
30. Golimbet VE, Alfimova MV, Shcherbatikh T, Kaleda V.G., Abramova LI, Rogaev E.I. (2003). Serotonin transporter gene polymorphism and schizoid personality traits in the patients with psychosis and psychiatrically well subjects. World J Biol Psychiatry 4:25-29.
31. Grabe HJ, Schwahn C, Mahler J., Appel K, Schulz A, Spitzer C., et al. (2012). Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse. Prog Neuropsycho-pharmacol Biol Psychiatry 36 (2-3):264-270.
32. Gratacos M, Gonzalez JR, Mercader J.M., De Cid R, Urretavizcaya M, Estivill X. (2007). Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 61:911-922. (Pubitemid 46420580)
33. Greenberg BD, Tolliver TJ, Huang S.J., Li Q., Bengel D, Murphy D.L. (1999). Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88:83-87. (Pubitemid 29075327)
34. Grunblatt E, Loffler C, Zehetmayer S., Jungwirth S, Tragl KH, Riederer P, Fischer P. (2006). Association study of the 5-HTTLPR polymorphism and depression in 75-year-old nondemented subjects from the Vienna Transdanube Aging (VITA) study. J Clin Psychiatry 670:1373-1378. (Pubitemid 44583384)
35. Haddley K, Bubb VJ, Breen G, Parades-Esquivel UM, Quinn J.P. (2012). Behavioural genetics of the serotonin transporter. Curr Top Behav Neurosci [Epub ahead of print].
36. Haenisch B, Herms S, Mattheisen M., Steffens M, Breuer R, Strohmaier J., et al. (2013). Genome-wide association data provide further support for an association between 5-HTTLPR and major depressive disorder. J Affect Disord 146:438-440.
37. Hall D, Dhilla A, Charalambous A., Gogos JA, Karayiorgou M. (2003). Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet 73: 370-376. (Pubitemid 36920998)
38. Hariri AR, Holmes A. (2006). Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci 4:182-191.
39. Hariri AR, Goldberg TE, Mattay V.S., Kolachana BS, Callicott JH, Egan MF, Weinberger D.R. (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23:6690-6694. (Pubitemid 36951196)
40. Hashimoto K (2010). Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin Neurosci 64:341-357.
41. Heils A, Mossner R, Lesch K.P. (1997). The human serotonin transporter gene polymorphism - basic research and clinical implications. J Neural Transm 104:1005-1014. (Pubitemid 28031667)
42. Heils A, Teufel A, Petri S., Stober G, Riederer P, Bengel D., Lesch K.P. (1996). Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624. (Pubitemid 26159101)
43. Hu XZ, Lipsky RH, Zhu G, Akhtar L.A., Taubman J., Greenberg BD, et al (2006). Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78:815-826.
44. Hunnerkopf R, Strobel A, Gutknecht L., Brocke B, Lesch K.P. (2007). Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacology 32:2552-2560. (Pubitemid 350126836)
45. Jiang X, Xu K, Hoberman J., Tian F, Marko AJ, Waheed J.F., et al. (2005). BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsy-chopharmacology 30:1353-1361. (Pubitemid 40848089)
46. Karege F, Perret G, Bondolfi G., Schwald M, Bertschy G, Aubry J.M. (2002). Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109:143-148. (Pubitemid 34258493)
47. Kaufman J, Yang BZ, Douglas-Palumberi H, Grasso D., Lipschitz D, Houshyar S, et al (2006). Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 59:673-680.
48. Kendler KS, Kuhn JW, Vittum J, Prescott C.A., Riley B. (2005). The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 62:529-535. (Pubitemid 40628882)
49. Kim JM, Stewart R, Kim S.W., Yang SJ, Shin IS, Kim YH, Yoon J.S. (2007). Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry 62:423-428. (Pubitemid 47284032)
50. Kim SJ, Cho SJ, Jang H.M., Shin J., Park PW, Lee YJ, et al (2010). Interaction between brain-derived neurotrophic factor Val66Met polymorphism and recent negative stressor in harm avoidance. Neuropsychobiology 61:19-26.
51. Klein AB, Santini MA, Aznar S, Knudsen G.M., Rios M. (2010). Changes in 5-HT2A-mediated behavior and 5-HT2A-and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice. Neuroscience 169:1007-1016.
52. Lang UE, Hellweg R, Kalus P., Bajbouj M, Lenzen KP, Sander T, et al (2005). Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) 180:95-99. (Pubitemid 40897075)
53. Lesch KP, Bengel D, Heils A., Sabol SZ, Greenberg BD, Petri S, et al (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531. (Pubitemid 26403928)
54. Licinio J, Dong C, Wong M.L. (2009). Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response. Arch Gen Psychiatry 66:488-497.
55. Lohoff FW, Sander T, Ferraro T.N., Dahl JP, Gallinat J, Berrettini W.H. (2005). Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet 139B:51-53. (Pubitemid 41552298)
56. Lopez-Leon S., Janssens AC, Gonzalez-Zuloeta Ladd AM, Del-Favero J, Claes SJ, Oostra BA, Van Duijn CM (2008). Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry 13:772-785. (Pubitemid 352032108)
57. Mann JJ, Huang YY, Underwood M.D., Kassir SA, Oppenheim S, Kelly TM, et al (2000). A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57:729-738. (Pubitemid 30650106)
58. Martinowich K, Lu B. (2008). Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33:73-83. (Pubitemid 350191318)
59. Matsushita S, Suzuki K, Murayama M., Nishiguchi N, Hishimoto A, Takeda A., et al. (2004). Serotonin transporter regulatory region polymorphism is associated with anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet 128B:114-117. (Pubitemid 38849929)
60. McAllister AK, Katz LC, Lo D.C. (1999). Neurotrophins and synaptic plasticity. Annu Rev Neurosci 22:295-318. (Pubitemid 29144890)
61. Mendlewicz J, Massat I, Souery D., Del-Favero J, Oruc L, Nothen M.M., et al. (2004). Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study. Eur J Hum Genet 12:377-382. (Pubitemid 38660188)
62. Murer MG, Boissiere F, Yan Q., Hunot S, Villares J, Faucheux B., et al. (1999). An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience 88:1015-1032. (Pubitemid 28546985)
63. Nederhof E, Bouma EM, Oldehinkel A.J., Ormel J. (2010). Interaction between childhood adversity, brain-derived neurotrophic factor val/met and serotonin transporter promoter polymorphism on depression: the TRAILS study. Biol Psychiatry 68:209-212.
64. Neff CD, Abkevich V, Potter J., Riley R, Shattuck D, Katz D.A. (2010). Evidence for epistasis between SLC6A4 and a chromosome 4 gene as risk factors in major depression. Am J Med Genet B Neuropsychiatr Genet 153B:321-322.
65. Neves-Pereira M., Mundo E, Muglia P., King N, Macciardi F, Kennedy J.L. (2002). The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 71:651-655. (Pubitemid 34970137)
66. Nugent NR, Tyrka AR, Carpenter L.L., Price L.H. (2011). Gene-environment interactions: early life stress and risk for depressive and anxiety disorders. Psychopharmacology (Berl) 214:175-196.
67. Oswald P, Del-Favero J, Massat I., Souery D, Claes S, Van Broeckhoven C, Mendlewicz J (2005). No implication of brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: evidence from Belgian first and replication patient-control studies. Eur Neuropsychopharmacol 15: 491-495. (Pubitemid 41219618)
68. Pezawas L, VerchinskI BA, Mattay V.S., Callicott JH, Kolachana BS, Straub RE, et al (2004). The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24:10099-10102. (Pubitemid 39492034)
69. Pezawas L, Meyer-Lindenberg A, Drabant E.M., Verchinski BA, Munoz KE, Kolachana BS, et al (2005). 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 8:828-834. (Pubitemid 43085851)
70. Pezawas L, Meyer-Lindenberg A, Goldman A.L., Verchinski BA, Chen G, Kolachana BS, et al (2008). Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry 13:709-716. (Pubitemid 351861533)
71. Pittenger C, Duman R.S. (2008). Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33:88-109. (Pubitemid 350191319)
72. Poo MM (2001). Neurotrophins as synaptic modulators. Nat Rev Neurosci 2:24-32.
73. Ren-Patterson R.F., Cochran LW, Holmes A, Sherrill S., Huang SJ, Tolliver T, et al (2005). Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J Neurosci Res 79:756-771. (Pubitemid 40476500)
74. Ribeiro L, Busnello JV, Cantor R.M., Whelan F., Whittaker P, Deloukas P, et al (2007). The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans. Neuroreport 18:1291-1293. (Pubitemid 47075599)
75. Rios M, Fan G, Fekete C., Kelly J, Bates B, Kuehn R., et al. (2001). Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15:1748-1757. (Pubitemid 32939305)
76. Rotondo A, Mazzanti C, Dell'Osso L, Rucci P, Sullivan P, Bouanani S, et al. (2002). Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. Am J Psychiatry 159:23-29. (Pubitemid 41070722)
77. Schumacher J, Jamra RA, Becker T, Ohlraun S., Klopp N, Binder EB, et al (2005). Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 58:307-314. (Pubitemid 41133624)
78. Sen S, Nesse RM, Stoltenberg S.F., Li S., Gleiberman L, Chakravarti A, et al (2003). A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsycho- pharmacology 28:397-401.
79. Sklar P, Gabriel SB, McInnis M.G., Bennett P., Lim YM, Tsan G, et al (2002). Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 7:579-593.
80. Strauss J, Barr CL, George C.J., King N., Shaikh S, Devlin B, et al (2004). Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. Am J Med Genet B Neuropsychiatr Genet 131B:16-19. (Pubitemid 39458432)
81. Strauss J, Barr CL, George C.J., Devlin B., Vetro A, Kiss E, et al (2005). Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: confirmation in a Hungarian sample. Mol Psychiatry 10: 861-867. (Pubitemid 43080120)
82. Suchanek R, Owczarek A, Kowalczyk M., Kuci K, Kowalski J. (2011). Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population. J Mol Neurosci 43:524-530.
83. Terracciano A, Tanaka T, Sutin A.R., Deiana B., Balaci L, Sanna S, et al (2010). BDNF Val66Met is associated with introversion and interacts with 5-HTTLPR to influence neuroticism. Neuropsychopharmacology 35:1083-1089.
84. Uher R, McGuffin P. (2008). The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry 13:131-146.
85. Veletza S, Samakouri M, Emmanouil G., Trypsianis G, Kourmouli N, Livaditis M. (2009). Psychological vulnerability differences in students - carriers or not of the serotonin transporter promoter allele S: effect of adverse experiences. Synapse 63:193-200.
86. Verhagen M, Van Der Meij A, Van Deurzen PA, Janzing JG, Arias-Vasquez A, Buitelaar JK, Franke B (2010). Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry 15:260-271.
87. Wells TT, Beevers CG, McGeary J.E. (2010). Serotonin transporter and BDNF genetic variants interact to predict cognitive reactivity in healthy adults. J Affect Disord 126 (1-2):223-229.
88. Wichers M, Kenis G, Jacobs N., Mengelers R, Derom C, Vlietinck R., Van Os J (2008). The BDNF Val(66)Met x 5-HTTLPR x child adversity interaction and depressive symptoms: an attempt at replication. Am J Med Genet B Neuropsychiatr Genet 147B:120-123.
89. Willis-Owen S.A., Fullerton J, Surtees P.G., Wainwright NW, Miller S, Flint J. (2005). The Val66Met coding variant of the brain-derived neurotrophic factor (BDNF) gene does not contribute toward variation in the personality trait neuroticism. Biol Psychiatry 58:738-742. (Pubitemid 41547242)
90. Zalsman G, Huang YY, Oquendo M.A., Burke AK, Hu XZ, Brent DA, et al (2006). Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry 163:1588-1593. (Pubitemid 44465760)
91. Zung WW (1965). A Self-Rating Depression Scale. Arch Gen Psychiatry 12: 63-70.